Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07368972 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of DISC-0974-201 in Participants With IBD and Anemia

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 15 sites
  2. Study sites: 14 to 15
    • Eligibility criteria expanded, about 57 words
    • Secondary endpoints: details revised at 1 of 13 entries
  3. Study sites: 13 to 14v12
  4. Study sites: 12 to 13v11
  5. Study sites: 11 to 12v10
Show 8 earlier versionsHide 8 earlier versions
  1. Study sites: 10 to 11v9
  2. Study sites: 9 to 10v8
  3. Study sites: 8 to 9v7
  4. Study sites: 6 to 8v6
  5. Study sites: 5 to 6v5
  6. Study sites: 3 to 5v4
  7. Study sites: 1 to 3v3
  8. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2026 to Feb 20, 2026
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Trial Details
NCT Number NCT07368972
Lead Sponsor Disc Medicine, Inc
Conditions
(from sponsor)		 Inflammatory Bowel Disease (IBD), Anemia, Inflammatory Bowel Disease (IBD); Anemia
Related terms Anemia, Inflammatory Bowel Diseases
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov